JPRN-UMIN000013438已完成未知
Prevention of Restenosis by Concomitant Tibial artery interventions after EndoVascular Treatment in FemoroPopliteal artery diseases complicated with Poor Runoff - ConTibi-FP
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Life expectancy within 6months 2)allergy of contrast agents 3)under 20 years old 4)inappropiriate patients determined from study director 5)patients unavailable of antiplatelet agents and anticoagulant 6)Critical limb ischemia patients that revascularization to below-the-knee artery is scheduled
研究者
相似试验
招募中
不适用
Prevention of Late Stent Thrombosis by an Interdisciplinary Global European effortNL-OMON47161Sint Antonius Ziekenhuis3,000
Unknown
2 期
PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary LesionsCoronary Artery DiseaseDiabetes MellitusNCT00116792Gold, Herman K., MD120
Unknown
3 期
PIoglitazone for PrEvention of Restenosis in Diabetic PatientsCoronary AtherosclerosisCoronary RestenosisDiabetesNCT00376870University of Rome Tor Vergata160
已完成
2 期
Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary ArteriesCoronary Artery DiseaseNCT00732953University of Ulm120
Unknown
2 期
Tissue Kallikrein Preventing the Restenosis After Stenting of Symptomatic MCA Atherosclerotic StenosisCerebrovascular DiseaseNCT01558245Jinling Hospital, China99